STRIDES PHARMA SCIENCE
Back to Income Statement
|
STRIDES PHARMA SCIENCE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹556 Cr | ₹3,593 Cr | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr |
What is the latest Consolidated Net Profit of STRIDES PHARMA SCIENCE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹556 Cr |
| Mar2025 | ₹3,593 Cr |
| Mar2024 | ₹-71 Cr |
| Mar2023 | ₹-203 Cr |
| Mar2022 | ₹-460 Cr |
How is Consolidated Net Profit of STRIDES PHARMA SCIENCE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹556 Cr | -84.52 | |
| Mar2025 | ₹3,593 Cr | Positive | |
| Mar2024 | ₹-71 Cr | Negative | |
| Mar2023 | ₹-203 Cr | Negative | |
| Mar2022 | ₹-460 Cr | - | |
Compare Consolidated Net Profit of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹10,306.6 Cr | -7.1% | 9.1% | 38.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | -7.1% |
9.1% |
38.5% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses